Matches in Wikidata for { <http://www.wikidata.org/entity/Q72769183> ?p ?o ?g. }
- Q72769183 description "article scientifique publié en 1994" @default.
- Q72769183 description "artikull shkencor i botuar më 01 shkurt 1994" @default.
- Q72769183 description "artículu científicu espublizáu en febreru de 1994" @default.
- Q72769183 description "im Februar 1994 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72769183 description "scientific article published on 01 February 1994" @default.
- Q72769183 description "wetenschappelijk artikel" @default.
- Q72769183 description "наукова стаття, опублікована в лютому 1994" @default.
- Q72769183 name "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 name "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 name "Immune function of patients receiving recombinant human interleukin-6" @default.
- Q72769183 type Item @default.
- Q72769183 label "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 label "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 label "Immune function of patients receiving recombinant human interleukin-6" @default.
- Q72769183 prefLabel "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 prefLabel "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 prefLabel "Immune function of patients receiving recombinant human interleukin-6" @default.
- Q72769183 P1433 Q72769183-B81C6BD6-EEAF-4C82-98CE-0DE74C029A64 @default.
- Q72769183 P1476 Q72769183-5129BD23-B4E3-4489-ACE0-90C39F1AB2C9 @default.
- Q72769183 P2093 Q72769183-1B3F1D5E-FF82-4A49-94DA-F3D27C262E41 @default.
- Q72769183 P2093 Q72769183-6CF4BABE-3CFE-4B4D-8656-5736F1B749DF @default.
- Q72769183 P2093 Q72769183-9A839F54-C1CA-4180-A2AD-97A081DE6704 @default.
- Q72769183 P2093 Q72769183-BB0D3844-EB1F-430E-863C-A1EC6B73336D @default.
- Q72769183 P2093 Q72769183-E6D2046A-6E32-4718-85CE-D2DF5EF0A33C @default.
- Q72769183 P2860 Q72769183-0176F0B1-7A12-4DF1-B218-26D87C414AE9 @default.
- Q72769183 P2860 Q72769183-03647CFF-9F1F-43B0-8B87-D10EBE5A682E @default.
- Q72769183 P2860 Q72769183-0E9A7A5A-6A4F-4541-8020-CA41F0C601AD @default.
- Q72769183 P2860 Q72769183-2DEC1542-DFE3-4B9A-84B7-FF9D5F260C5B @default.
- Q72769183 P2860 Q72769183-2E6EF3B7-6E07-4A73-8987-882902E4BE1A @default.
- Q72769183 P2860 Q72769183-376322CE-AE8A-470E-A054-D1D200BF9D2C @default.
- Q72769183 P2860 Q72769183-3F1C7433-14CD-4033-B6BB-A05BFFAC69E9 @default.
- Q72769183 P2860 Q72769183-3F25B983-A55E-4B8E-BA78-6D68F46261FB @default.
- Q72769183 P2860 Q72769183-40EB9441-0766-4E4A-8C9B-9AC83ED92647 @default.
- Q72769183 P2860 Q72769183-4192DEA1-2DF5-465B-AD7E-408D1AB6FB7A @default.
- Q72769183 P2860 Q72769183-43031856-686C-4C48-9A92-19145D64E2A2 @default.
- Q72769183 P2860 Q72769183-43B9BB07-822C-4588-9366-872D1C709FBC @default.
- Q72769183 P2860 Q72769183-47608BEA-030B-443C-9D1D-D17DEC18400C @default.
- Q72769183 P2860 Q72769183-4D0AF7DE-171D-44B8-BF14-56911B9DC409 @default.
- Q72769183 P2860 Q72769183-4FAB573E-5B5D-495E-8572-A9B06C85348C @default.
- Q72769183 P2860 Q72769183-5AAE7AD6-88C7-4FF2-ADFF-5124881DFC9A @default.
- Q72769183 P2860 Q72769183-5BC92DEF-D237-4E68-8382-B704E3A254EE @default.
- Q72769183 P2860 Q72769183-5BD1E881-457A-4B4B-944D-BC419872C94B @default.
- Q72769183 P2860 Q72769183-65EC376C-5B7B-4F4B-99B0-B64F68822357 @default.
- Q72769183 P2860 Q72769183-6C67880D-408C-471C-A62B-2D89232A98FE @default.
- Q72769183 P2860 Q72769183-6D622E05-7DDA-4B45-81A7-8AD0874183EC @default.
- Q72769183 P2860 Q72769183-6E7C1B1A-B0C7-48CF-929B-73EE6784D1B1 @default.
- Q72769183 P2860 Q72769183-6F5E6462-7AD2-4966-AA57-D8999FB0AEBE @default.
- Q72769183 P2860 Q72769183-6F631B1C-53C7-426F-886B-E0C9E20B777C @default.
- Q72769183 P2860 Q72769183-72A2A8F2-B480-4D7F-BEE0-CF2C6D667F13 @default.
- Q72769183 P2860 Q72769183-7967F9C3-BC08-4F51-9D45-9CF71D3CE58A @default.
- Q72769183 P2860 Q72769183-7A6F2825-28F2-4B0C-9BB3-D0629DEEC86B @default.
- Q72769183 P2860 Q72769183-7D3D1E5B-0156-4292-B862-1DB5C3661850 @default.
- Q72769183 P2860 Q72769183-80457559-3B80-4014-9DEA-826D81770499 @default.
- Q72769183 P2860 Q72769183-8163D58F-5DC4-4EC0-ABC0-EEDA0E4F34FA @default.
- Q72769183 P2860 Q72769183-816CD5EE-42D1-4D30-8891-6FBD03DB109C @default.
- Q72769183 P2860 Q72769183-88E7322C-2604-4C5D-A10C-508D4D238024 @default.
- Q72769183 P2860 Q72769183-8F332992-EDD5-45F6-848B-490B7695FDAB @default.
- Q72769183 P2860 Q72769183-91560D56-2D77-41AA-8067-642BB82C3501 @default.
- Q72769183 P2860 Q72769183-9CFF25A9-FE4C-4EAF-9F3B-DB579FC764AE @default.
- Q72769183 P2860 Q72769183-9DDD3E97-8C61-4F22-9E88-AD7DC180A51C @default.
- Q72769183 P2860 Q72769183-A58F43E3-CB4A-425B-95DA-E7078A7B60B2 @default.
- Q72769183 P2860 Q72769183-ACD20070-B8A5-4274-B674-4F1C32D27AD9 @default.
- Q72769183 P2860 Q72769183-AE80AFD5-F827-45D3-BF9A-B30F10AF0B8B @default.
- Q72769183 P2860 Q72769183-AFE02334-F609-43F3-913F-1468B72B7F8D @default.
- Q72769183 P2860 Q72769183-AFE0970B-A474-4AC6-B60F-7518E4229F84 @default.
- Q72769183 P2860 Q72769183-B13F7284-EDA0-4A59-BFAC-9F5CB021D261 @default.
- Q72769183 P2860 Q72769183-B2FD1C1C-A705-4B36-9E2B-E119CC74F3BE @default.
- Q72769183 P2860 Q72769183-B4BE211D-5AD4-4443-9F6A-57EB25C00E97 @default.
- Q72769183 P2860 Q72769183-C045495D-B996-4CD4-A856-D1F5568942A7 @default.
- Q72769183 P2860 Q72769183-C8C5CFBE-C2C0-45FE-86F0-96438FC65BD9 @default.
- Q72769183 P2860 Q72769183-CC73228A-DF4D-4B29-978F-491FD56C247F @default.
- Q72769183 P2860 Q72769183-CC85525B-0CFF-4B03-8796-6451C34A1DEB @default.
- Q72769183 P2860 Q72769183-DC73F635-3072-408C-A17E-9FDBA709754B @default.
- Q72769183 P2860 Q72769183-E0B09B0D-C5FE-4128-BA19-84A871333BB9 @default.
- Q72769183 P2860 Q72769183-E1127E04-B4C2-4DE2-8F99-60B1A22928A0 @default.
- Q72769183 P2860 Q72769183-E1E74F5A-A681-49A1-92A9-E82D386A5C4F @default.
- Q72769183 P2860 Q72769183-E6BAC0BE-DD5C-4E76-9A33-E6BB5A592EE5 @default.
- Q72769183 P2860 Q72769183-E85C57E2-CEA3-4398-8924-0CB5AB33753D @default.
- Q72769183 P2860 Q72769183-F45CB3D9-228F-4BEE-A476-B933C8BF594A @default.
- Q72769183 P2860 Q72769183-FB08CA21-B612-453F-BB82-EA65227278C5 @default.
- Q72769183 P2860 Q72769183-FE1E9772-F063-489C-BD1C-06197D8EEAF0 @default.
- Q72769183 P2888 Q72769183-B8E63ED8-A833-4642-AA5B-1FAB89DC32D7 @default.
- Q72769183 P304 Q72769183-45CD1376-3E80-45B2-A5F1-2423D7011DEC @default.
- Q72769183 P31 Q72769183-729E6D2E-882B-4C2F-9A65-38FB627415CC @default.
- Q72769183 P356 Q72769183-754F6557-8631-4662-86A6-E10F7FB70097 @default.
- Q72769183 P433 Q72769183-D64A4619-61FC-4134-8AF2-E366DAAAF1D2 @default.
- Q72769183 P478 Q72769183-E707E7CB-6FEC-41E1-A59E-59D9DBB59D79 @default.
- Q72769183 P50 Q72769183-71709A95-A89F-47BD-90BD-E710EBE0010D @default.
- Q72769183 P577 Q72769183-6C044E69-78E3-42BC-86A5-95211424FEDF @default.
- Q72769183 P698 Q72769183-387B1C95-9D8C-439B-B687-AB16A5812FCC @default.
- Q72769183 P921 Q72769183-2D3466B2-6FB3-49E1-8F2C-264D48BED813 @default.
- Q72769183 P356 BF01526207 @default.
- Q72769183 P698 8306367 @default.
- Q72769183 P1433 Q5031409 @default.
- Q72769183 P1476 "Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity" @default.
- Q72769183 P2093 "C Scheid" @default.
- Q72769183 P2093 "J H Scarffe" @default.
- Q72769183 P2093 "L Fitzsimmons" @default.
- Q72769183 P2093 "R McDermott" @default.
- Q72769183 P2093 "R Young" @default.